Global Market Report

Blockbuster Oncology Brands Market Report 2020-2030

There will be growth in both established and in developing countries. Our analyses show that the both developed and developing markets, U.S., Germany, UK and India, China in particular, will continue to achieve high revenue growth to 2030.

SKU: PHA0752 Category: Tags: , Code: PHA0752Pages: 156
Clear
โ† Back to category Therapeutic Drugs

Description

Blockbuster Oncology Brands,our new study reveals trends, R&D progress, and predicted revenues
Where is the Blockbuster Oncology Brands Market heading? If you are involved in this sector you must read this newly updated report. Visiongain’s report shows you the potential revenues streams to 2030, assessing data, trends, opportunities and business prospects there.

Discover how to stay ahead
Our 150+ page report provides 100+ tables and charts/graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Blockbuster Oncology Brands Market. See how to exploit the opportunities.

Forecasts to 2030 and other analyses reveal the commercial prospects
โ€ข In addition to revenue forecasting to 2030, our new study provides you with recent results, growth rates, and market shares.
โ€ข You find original analyses, with business outlooks and developments.
โ€ข Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.

Discover sales predictions for the world market and submarkets

Global Blockbuster Oncology Brands Market by Brands
โ€ข Opdivo
โ€ข Keytruda
โ€ข Perjeta
โ€ข Ibrance
โ€ข Tecentriq
โ€ข Gazyva
โ€ข Tagrisso
โ€ข Others

Global Blockbuster Oncology Brands Market by Indication
โ€ข Lung cancer
โ€ข Breast cancer
โ€ข Multiple myeloma
โ€ข Lymphoma
โ€ข Others

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 17 leading national markets:

โ€ข North America:
โ€ข U.S.
โ€ข Canada

โ€ข Latin America:
โ€ข Brazil
โ€ข Mexico
โ€ข Rest of Latin America

โ€ข Europe:
โ€ข Germany
โ€ข France
โ€ข UK
โ€ข Italy
โ€ข Spain
โ€ข Russia
โ€ข Rest of Europe

โ€ข Asia-Pacific:
โ€ข Japan
โ€ข China
โ€ข India
โ€ข Australia
โ€ข ASEAN
โ€ข Rest of Asia-Pacific

โ€ข MEA:
โ€ข GCC Countries
โ€ข South Africa
โ€ข Rest of MEA

The report also includes profiles and for some of the leading companies in the Blockbuster Oncology Brands Market, with a focus on this segment of these companies’ operations.

There will be growth in both established and in developing countries. Our analyses show that the both developed and developing markets, U.S., Germany, UK and India, China in particular, will continue to achieve high revenue growth to 2030.

Leading companies and the potential for market growth
Overall world revenue for Blockbuster Oncology Brands Market will surpass $xyz billion in 2020, our work calculates. We predict strong revenue growth through to 2030.

To access the data contained in this document please email contactus@visiongain.com

Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How the Blockbuster Oncology Brands Market report helps you
In summary, our 150+ page report provides you with the following knowledge:

โ€ข Revenue forecasts to 2030 for Blockbuster Oncology Brands Market, with forecasts for Brands, Indication, each forecasted at a global and regional level, discover the industry’s prospects, finding the most lucrative places for investments and revenues

โ€ข Revenue forecasts to 2030 for 5 regional and 17 key national markets , See forecasts for the Blockbuster Oncology Brands Market in North America, Latin America, Europe, Asia-Pacific and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, Spain, Russia, China, India, Japan, Australia, ASEAN countries, GCC Countries and South Africa.

โ€ข Prospects for established firms and those seeking to enter the market, including company profiles the major companies involved in the Blockbuster Oncology Brands Market

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions.

Visiongain’s study is for everybody needing commercial analyses for the Blockbuster Oncology Brands Market and leading companies. You will find data, trends and predictions.

Buy our report today Blockbuster Oncology Brands Market Report 2020-2030: Forecasts by Brands (Opdivo, Keytruda, Perjeta, Ibrance, Tecentriq, Gazyva, Tagrisso, Others), Indication (Lung Cancer, Breast Cancer, Multiple Myeloma, Lymphoma, Others), and Geography (North America, Latin America, Europe, Asia Pacific, MEA). Avoid missing out by staying informed , order our report now.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: contactus@visiongain.com

1. Report Overview
1.1. Introduction
1.2. Why You Should Read This Report
1.3. Key Questions Answered by This Analytical Report
1.4. Who is This Report For?
1.5. Methodology
1.6. Frequently Asked Questions (FAQ)
1.7. Associated Visiongain Reports
1.8. About Visiongain

2. Blockbuster Oncology Brands Market Overview
2.1. Introduction
2.1.1. Market Definition
2.1.2. Market Taxonomy
2.2. Global Blockbuster Oncology Brands Market Size and Forecast
2.3. Market Dynamics
2.3.1. Market Drivers
2.3.1.1. Quick approvals
2.3.1.2. Immuno-Oncology Therapies as First Line Treatment
2.3.2. Market Restraints/Challenges
2.3.2.1. High Therapy Costs challenges market access
2.3.3. Global Blockbuster Oncology Brands Market: Trends
2.3.4. Mergers and Acquisitions
2.3.5. Entry of New Market Players
2.4. SWOT Analysis
2.5. Porter's Five Forces Analysis
2.6. PEST Analysis
2.7. COVID-19 Impact Analysis
2.7.1. Qualitative Analysis
2.7.2. Revenues & Forecast (Pre-COVID-19 v.s. Post-COVID-19)
2.7.3. Post COVID-19 Impact Analysis
2.7.3.1. V Shaped Recovery
2.7.3.2. U Shaped Recovery
2.7.3.3. L Shaped Recovery
2.7.3.4. W Shaped Recovery
2.7.4. Impact on Healthcare Industry
2.7.5. Impact of COVID-19 on GDP and Trade

3. Global Blockbuster Oncology Brands Market Analysis and Forecast, By Brands
3.1. Introduction
3.1.1. Global Blockbuster Oncology Brands Market, Annual Growth Rate Comparison by Brands
3.1.2. Global Blockbuster Oncology Brands Market Share Comparison by Brands, (2020, 2025, 2030)
3.2. Global Blockbuster Oncology Brands Market Size and Forecast by Brands
3.2.1. Opdivo
3.2.2. Keytruda
3.2.3. Perjeta
3.2.4. Ibrance
3.2.5. Tecentriq
3.2.6. Gazyva
3.2.7. Tagrisso
3.2.8. Others
3.3. Global Blockbuster Oncology Brands Attractiveness Index by Brands

4. Global Blockbuster Oncology Brands Market Analysis and Forecast by Indication
4.1. Introduction
4.1.1. Global Blockbuster Oncology Brands Market, Annual Growth Rate Comparison by Indication
4.1.2. Global Blockbuster Oncology Brands Market Share Comparison by Indication, (2020, 2025, 2030)
4.2. Global Blockbuster Oncology Brands Market Size and Forecast by Indication
4.2.1. Lung cancer
4.2.2. Breast cancer
4.2.3. Multiple myeloma
4.2.4. Lymphoma
4.2.5. Others
4.3. Global Blockbuster Oncology Brands Attractiveness Index by Indication

5. Global Blockbuster Oncology Brands Market Analysis and Forecast by Region
5.1. Introduction
5.1.1. Global Blockbuster Oncology Brands Market, Annual Growth Rate Comparison by Region
5.1.2. Global Blockbuster Oncology Brands Market Share Comparison by Region (2020, 2025, 2030)
5.2. Global Blockbuster Oncology Brands Market Size and Forecast by Region
5.2.1. North America (U.S., Canada)
5.2.2. Latin America (Brazil, Mexico, Rest of Latin America)
5.2.3. Europe (UK, France, Germany, Italy, Spain, Russia, RoEU)
5.2.4. Asia Pacific (Japan, China, India, ASEAN, Australia, RoAPAC)
5.2.5. MEA (GCC, South Africa, RoMEA)
5.3. Global Blockbuster Oncology Brands Market Attractiveness Index by Region

6. North America Blockbuster Oncology Brands Market Analysis and Forecast, 2020-2030
6.1. Introduction
6.1.1. North America Blockbuster Oncology Brands Market
6.1.2. North America Blockbuster Oncology Brands Market, Annual Growth Rate Comparison by Country
6.2. North America Blockbuster Oncology Brands Market Size and Forecast by Country
6.2.1. The U.S. Blockbuster Oncology Brands Market
6.2.2. Canada Blockbuster Oncology Brands Market
6.3. North America Blockbuster Oncology Brands Market Size and Forecast by Brands
6.4. North America Blockbuster Oncology Brands Market Size and Forecast by Indication
6.5. North America Blockbuster Oncology Brands Market Attractiveness Index by Country

7. Latin America Blockbuster Oncology Brands Market Analysis and Forecast, 2020-2030
7.1. Introduction
7.1.1. Latin America Blockbuster Oncology Brands Market
7.1.2. Latin America Blockbuster Oncology Brands Market, Annual Growth Rate Comparison by Country
7.2. Latin America Blockbuster Oncology Brands Market Size and Forecast by Country
7.2.1. Brazil Blockbuster Oncology Brands Market
7.2.2. Mexico Blockbuster Oncology Brands Market
7.2.3. Rest of Latin America Blockbuster Oncology Brands Market
7.3. Latin America Blockbuster Oncology Brands Market Size and Forecast by Brands
7.4. Latin America Blockbuster Oncology Brands Market Size and Forecast by Indication
7.5. Latin America Blockbuster Oncology Brands Market Attractiveness Index by Country

8. Europe Blockbuster Oncology Brands Market Analysis and Forecast, 2020-2030
8.1. Introduction
8.1.1. Europe Blockbuster Oncology Brands Market
8.1.2. Europe Blockbuster Oncology Brands Market, Annual Growth Rate Comparison by Country
8.2. Europe Blockbuster Oncology Brands Market Size and Forecast by Country
8.2.1. U.K. Blockbuster Oncology Brands Market
8.2.2. France Blockbuster Oncology Brands Market
8.2.3. Germany Blockbuster Oncology Brands Market
8.2.4. Italy Blockbuster Oncology Brands Market
8.2.5. Spain Blockbuster Oncology Brands Market
8.2.6. Russia Blockbuster Oncology Brands Market
8.2.7. Rest of Europe Blockbuster Oncology Brands Market
8.3. Europe Blockbuster Oncology Brands Market Size and Forecast by Brands
8.4. Europe Blockbuster Oncology Brands Market Size and Forecast by Indication
8.5. Europe Blockbuster Oncology Brands Market Attractiveness Index by Country

9. Asia Pacific Blockbuster Oncology Brands Market Analysis and Forecast, 2020-2030
9.1. Introduction
9.1.1. Asia Pacific Blockbuster Oncology Brands Market
9.1.2. Asia Pacific Blockbuster Oncology Brands Market, Annual Growth Rate Comparison by Country
9.2. Asia Pacific Blockbuster Oncology Brands Market Size and Forecast by Country
9.2.1. China Blockbuster Oncology Brands Market
9.2.2. India Blockbuster Oncology Brands Market
9.2.3. Australia Blockbuster Oncology Brands Market
9.2.4. ASEAN Blockbuster Oncology Brands Market
9.2.5. Japan Blockbuster Oncology Brands Market
9.2.6. Rest of Asia Pacific Blockbuster Oncology Brands Market
9.3. Asia Pacific Blockbuster Oncology Brands Market Size and Forecast by Brands
9.4. Asia Pacific Blockbuster Oncology Brands Market Size and Forecast by Indication
9.5. Asia Pacific Blockbuster Oncology Brands Market Attractiveness Index by Country

10. MEA Blockbuster Oncology Brands Market Analysis and Forecast, 2020-2030
10.1. Introduction
10.1.1. MEA Blockbuster Oncology Brands Market
10.1.2. MEA Blockbuster Oncology Brands Market, Annual Growth Rate Comparison by Country
10.2. MEA Blockbuster Oncology Brands Market Size and Forecast by Country
10.2.1. GCC Blockbuster Oncology Brands Market
10.2.2. South Africa Blockbuster Oncology Brands Market
10.2.3. Rest of MEA Blockbuster Oncology Brands Market
10.3. MEA Blockbuster Oncology Brands Market Size and Forecast by Brands
10.4. MEA Blockbuster Oncology Brands Market Size and Forecast by Indication
10.5. MEA Blockbuster Oncology Brands Market Attractiveness Index by Country

11. Leading Companies in the Blockbuster Oncology Brands Market
11.1. Competition Dashboard
11.2. Company Share Analysis
11.3. Leading Players
11.4. Astrazeneca
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance (2015-2019)
11.4.4. Recent Initiatives
11.5. Bristol Myers Squibb
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance (2015-2019)
11.5.4. Recent Initiatives
11.6. Merck & Co.
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance (2015-2019)
11.6.4. Recent Initiatives
11.7. Pfizer
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance (2015-2019)
11.7.4. Recent Initiatives
11.8. Roche
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance (2015-2019)
11.8.4. Recent Initiatives
11.9. Tesaro
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance (2015-2019)
11.9.4. Recent Initiatives

12. Conclusion

13. Glossary

14. Appendix

LIST OF TABLES
Table 1 Global Blockbuster Oncology Brands Market Size by Region, 2020-2030 (USD Mn, CAGR%)
Table 2 Global Blockbuster Oncology Brands Market Size by Brands, 2020-2030 (USD Mn, CAGR%)
Table 3 Global Blockbuster Oncology Brands Market Size by Indication, 2020-2030 (USD Mn, CAGR%)
Table 4 North America: Blockbuster Oncology Brands Market Size by Country, 2020-2030 (USD Mn, CAGR%)
Table 5 North America: Blockbuster Oncology Brands Market Size by Brands, 2020-2030 (USD Mn, CAGR%)
Table 6 North America: Blockbuster Oncology Brands Market Size by Indication, 2020-2030 (USD Mn, CAGR%)
Table 7 U.S. Blockbuster Oncology Brands Market Size by Brands, 2020-2030 (USD Mn, CAGR%)
Table 8 U.S. Blockbuster Oncology Brands Market Size by Indication, 2020-2030 (USD Mn, CAGR%)
Table 9 Canada Blockbuster Oncology Brands Market Size by Brands, 2020-2030 (USD Mn, CAGR%)
Table 10 Canada Blockbuster Oncology Brands Market Size by Indication, 2020-2030 (USD Mn, CAGR%)
Table 11 Latin America: Blockbuster Oncology Brands Market Size by Country, 2020-2030 (USD Mn, CAGR%)
Table 12 Latin America: Blockbuster Oncology Brands Market Size by Brands, 2020-2030 (USD Mn, CAGR%)
Table 13 Latin America: Blockbuster Oncology Brands Market Size by Indication, 2020-2030 (USD Mn, CAGR%)
Table 14 Brazil Blockbuster Oncology Brands Market Size by Brands, 2020-2030 (USD Mn, CAGR%)
Table 15 Brazil Blockbuster Oncology Brands Market Size by Indication, 2020-2030 (USD Mn, CAGR%)
Table 16 Mexico Blockbuster Oncology Brands Market Size by Brands, 2020-2030 (USD Mn, CAGR%)
Table 17 Mexico Blockbuster Oncology Brands Market Size by Indication, 2020-2030 (USD Mn, CAGR%)
Table 18 Rest of Latin America Blockbuster Oncology Brands Market Size by Brands, 2020-2030 (USD Mn, CAGR%)
Table 19 Rest of Latin America Blockbuster Oncology Brands Market Size by Indication, 2020-2030 (USD Mn, CAGR%)
Table 20 Europe: Blockbuster Oncology Brands Market Size by Country, 2020-2030 (USD Mn, CAGR%)
Table 21 Europe: Blockbuster Oncology Brands Market Size by Brands, 2020-2030 (USD Mn, CAGR%)
Table 22 Europe: Blockbuster Oncology Brands Market Size by Indication, 2020-2030 (USD Mn, CAGR%)
Table 23 Germany Blockbuster Oncology Brands Market Size by Brands, 2020-2030 (USD Mn, CAGR%)
Table 24 Germany Blockbuster Oncology Brands Market Size by Indication, 2020-2030 (USD Mn, CAGR%)
Table 25 UK Blockbuster Oncology Brands Market Size by Brands, 2020-2030 (USD Mn, CAGR%)
Table 26 UK Blockbuster Oncology Brands Market Size by Indication, 2020-2030 (USD Mn, CAGR%)
Table 27 France Blockbuster Oncology Brands Market Size by Brands, 2020-2030 (USD Mn, CAGR%)
Table 28 France Blockbuster Oncology Brands Market Size by Indication, 2020-2030 (USD Mn, CAGR%)
Table 29 Italy Blockbuster Oncology Brands Market Size by Brands, 2020-2030 (USD Mn, CAGR%)
Table 30 Italy Blockbuster Oncology Brands Market Size by Indication, 2020-2030 (USD Mn, CAGR%)
Table 31 Spain Blockbuster Oncology Brands Market Size by Brands, 2020-2030 (USD Mn, CAGR%)
Table 32 Spain Blockbuster Oncology Brands Market Size by Indication, 2020-2030 (USD Mn, CAGR%)
Table 33 Russia Blockbuster Oncology Brands Market Size by Brands, 2020-2030 (USD Mn, CAGR%)
Table 34 Russia Blockbuster Oncology Brands Market Size by Indication, 2020-2030 (USD Mn, CAGR%)
Table 35 Rest of Europe Blockbuster Oncology Brands Market Size by Brands, 2020-2030 (USD Mn, CAGR%)
Table 36 Rest of Europe Blockbuster Oncology Brands Market Size by Indication, 2020-2030 (USD Mn, CAGR%)
Table 37 APAC: Blockbuster Oncology Brands Market Size by Country, 2020-2030 (USD Mn, CAGR%)
Table 38 APAC: Blockbuster Oncology Brands Market Size by Brands, 2020-2030 (USD Mn, CAGR%)
Table 39 APAC: Blockbuster Oncology Brands Market Size by Indication, 2020-2030 (USD Mn, CAGR%)
Table 40 Japan Blockbuster Oncology Brands Market Size by Brands, 2020-2030 (USD Mn, CAGR%)
Table 41 Japan Blockbuster Oncology Brands Market Size by Indication, 2020-2030 (USD Mn, CAGR%)
Table 42 China Blockbuster Oncology Brands Market Size by Brands, 2020-2030 (USD Mn, CAGR%)
Table 43 China Blockbuster Oncology Brands Market Size by Indication, 2020-2030 (USD Mn, CAGR%)
Table 44 India Blockbuster Oncology Brands Market Size by Brands, 2020-2030 (USD Mn, CAGR%)
Table 45 India Blockbuster Oncology Brands Market Size by Indication, 2020-2030 (USD Mn, CAGR%)
Table 46 Australia Blockbuster Oncology Brands Market Size by Brands, 2020-2030 (USD Mn, CAGR%)
Table 47 Australia Blockbuster Oncology Brands Market Size by Indication, 2020-2030 (USD Mn, CAGR%)
Table 48 ASEAN Blockbuster Oncology Brands Market Size by Brands, 2020-2030 (USD Mn, CAGR%)
Table 49 ASEAN Blockbuster Oncology Brands Market Size by Indication, 2020-2030 (USD Mn, CAGR%)
Table 50 Rest of APAC Blockbuster Oncology Brands Market Size by Brands, 2020-2030 (USD Mn, CAGR%)
Table 51 Rest of APAC Blockbuster Oncology Brands Market Size by Indication, 2020-2030 (USD Mn, CAGR%)
Table 52 MEA: Blockbuster Oncology Brands Market Size by Country, 2020-2030 (USD Mn, CAGR%)
Table 53 MEA: Blockbuster Oncology Brands Market Size by Brands, 2020-2030 (USD Mn, CAGR%)
Table 54 MEA: Blockbuster Oncology Brands Market Size by Indication, 2020-2030 (USD Mn, CAGR%)
Table 55 GCC Countries Blockbuster Oncology Brands Market Size by Brands, 2020-2030 (USD Mn, CAGR%)
Table 56 GCC Countries Blockbuster Oncology Brands Market Size by Indication, 2020-2030 (USD Mn, CAGR%)
Table 57 South Africa Blockbuster Oncology Brands Market Size by Brands, 2020-2030 (USD Mn, CAGR%)
Table 58 South Africa Blockbuster Oncology Brands Market Size by Indication, 2020-2030 (USD Mn, CAGR%)
Table 59 Rest of MEA Blockbuster Oncology Brands Market Size by Brands, 2020-2030 (USD Mn, CAGR%)
Table 60 Rest of MEA Blockbuster Oncology Brands Market Size by Indication, 2020-2030 (USD Mn, CAGR%)

LIST OF FIGURES
Figure 1 Blockbuster Oncology Brands Market Segmentation
Figure 2 Drivers, Restraints, Opportunities, and Challenges in the Blockbuster Oncology Brands Market
Figure 3 Value Chain Analysis
Figure 4 Porter's Five Forces Analysis
Figure 5 Global Blockbuster Oncology Brands Market by Brands (2020-2030)
Figure 6 Global Blockbuster Oncology Brands Market by Indication (2020-2030)
Figure 7 Global Blockbuster Oncology Brands Market by Region
Figure 8 North America Blockbuster Oncology Brands Market Snapshot
Figure 9 U.S. Blockbuster Oncology Brands Market, 2020-2030 (USD Mn)
Figure 10 Canada Blockbuster Oncology Brands Market, 2020-2030 (USD Mn)
Figure 11 Europe Blockbuster Oncology Brands Market Snapshot
Figure 12 Germany Blockbuster Oncology Brands Market, 2020-2030 (USD Mn)
Figure 13 France Blockbuster Oncology Brands Market, 2020-2030 (USD Mn)
Figure 14 UK Blockbuster Oncology Brands Market, 2020-2030 (USD Mn)
Figure 15 Italy Blockbuster Oncology Brands Market, 2020-2030 (USD Mn)
Figure 16 Spain Blockbuster Oncology Brands Market, 2020-2030 (USD Mn)
Figure 17 Russia Blockbuster Oncology Brands Market, 2020-2030 (USD Mn)
Figure 18 APAC Blockbuster Oncology Brands Market Snapshot
Figure 19 Japan Blockbuster Oncology Brands Market, 2020-2030 (USD Mn)
Figure 20 China Blockbuster Oncology Brands Market, 2020-2030 (USD Mn)
Figure 21 India Blockbuster Oncology Brands Market, 2020-2030 (USD Mn)
Figure 22 Australia Blockbuster Oncology Brands Market, 2020-2030 (USD Mn)
Figure 23 ASEAN Blockbuster Oncology Brands Market, 2020-2030 (USD Mn)
Figure 24 Latin America Blockbuster Oncology Brands Market Snapshot
Figure 25 Brazil Blockbuster Oncology Brands Market, 2020-2030 (USD Mn)
Figure 26 Mexico Blockbuster Oncology Brands Market, 2020-2030 (USD Mn)
Figure 27 MEA Blockbuster Oncology Brands Market Snapshot
Figure 28 GCC Countries Blockbuster Oncology Brands Market, 2020-2030 (USD Mn)
Figure 29 South Africa Blockbuster Oncology Brands Market, 2020-2030 (USD Mn)
Figure 30 Company Market Share Analysis
Figure 31 Astrazeneca Financial Snapshot
Figure 32 Bristol Myers Squibb Financial Snapshot
Figure 33 Merck & Co. Financial Snapshot
Figure 34 Pfizer Financial Snapshot
Figure 35 Roche Financial Snapshot
Figure 36 Tesaro Financial Snapshot

Astrazeneca
Bristol Myers Squibb
Merck & Co.
Pfizer
Roche
Tesaro